NewsNHS InsightsWebinars & PodcastsPharma

Specialised Commissioning in the NHS – What do you need to know now?

The proposed new NHS England (NHSE) systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects of policy have been published in ways that are hard to access and even harder to interpret.

In our webinar on Friday 2nd December, we gathered an expert panel to discuss what proposed new NHSE systems for specialised commissioning mean in practice.

In this NHS Whispers webinar, we explored:

  • What’s new for Specialised Commissioning and what’s set to change?
  • What are the potential implications of the proposed changes recently published?
  • Integrated Care Boards (ICBs) and their increasing role with Specialised Commissioning
  • What this means for the NHS and for industry in practice

The webinar began with an overview and analysis of the changes from David Thorne (Principal Associate, Mtech Access and Business Development Director, Well Up North PCN). David then opened up a broader discussion about the implications of these changes with our guest panellists James Curtis (Deputy Operational Director, Gloucestershire NHS Foundation Trust) and Mohammed Asghar (ICS Prescribing Governance Lead at Frimley Health and Care ICS).

About our speakers

James Curtis (Deputy Operational Director, Gloucestershire NHS Foundation Trust)

James has gained a wide range of operational management experience in roles with Gloucestershire Hospitals NHS Foundation Trust and Gloucestershire Care Services NHS Trust, including as General Manager for Cancer Services and Screening, where he had operational responsibility for coordinating cancer pathways.

Mohammed Asghar (ICS Prescribing Governance Lead at Frimley Health and Care ICS)

Mohammed has 20+ years’ experience in prescribing roles in the NHS. As Prescribing Governance Lead in an integrated care system, he is ideally placed to give a pharmacy perspective on the changes to specialised commissioning.

David Thorne (Principal Associate, Mtech Access and Business Development Director, Well Up North PCN)

David is an experienced healthcare professional with an impressive track record of delivery in the NHS and pharmaceutical industry. He is a leading UK authority figure on clinical commissioning and market access and has done an in-depth exploration of the recently published documents on Specialised Commissioning.

Listen to the podcast:

This episode is also available as a podcast. Listen below or search ‘Pharma Market Access Insights  – from Mtech Access’ on Spotify, Apple Podcasts or Google Podcasts.

This webinar is a special in our monthly Whispers’ Words of Wisdom series, in which we have in-depth, comprehensive conversations with senior colleagues from the NHS. We explore what their immediate priorities are, what they see as the greatest challenges currently faced by the NHS, and how the NHS might respond to these challenges.

Our previous webinars are available on demand:

Leave a Reply